Nicola p iq option
It s no wonder options make such attractive investment opportunities. Buy Real Weed Online Without Medical Card Order Marijuana 420 Mail Order Worldwide legit online dispensary shipping worldwide. 420 mail order marijuana patients 420 mail order USA credit card reviews. Buy Weed Online. Firstly, we have rick simpson oil rso with full extract cannabis oil that you can order online 420 mail order USA420 CA420 UK and 420 EU.
West Coast Cannabis is the best legal marijuana dispensary shipping to all 50 states and worldwide. Hence get legal weed for sale online or buy kush online UK without medical marijuana card. We package discreetly and ship directly t your doorsteps or into your mail-box. Consequently, search no more for cheap legit online dispensary shipping worldwide. 420 Mail Order Weed Store.
Buy Real Weed Online UK 420 Mail Order Worldwide. Order Marijuana Online Without Medical Card. Mary s THC Honey Tears. Dried Shrooms Mushroom Dosage Calculator. Master Kush. Mary s Dog CBD Oil. Blue Amnesia. CBD CARA-MELTS Twisted Extract. 25mg THC Hemp Seed Oil Capsules CO2. Black Cherry INDICA 1 1 JELLY BOMBS Twisted Extracts. ACDC THC Oil 1 gram.
Grand Daddy Purp GrandDaddy Purple Kush. CBD Medicated Dog Treats CBD Goodies. 200mg THC infused Dark Chocolate Adorable. Platinum OG THC Oil. Moon Rocks Weed Kurupt s Moonrock. Mary s Westcoast Teddies Triple Strength Indica. 50mg THC Hemp Seed Oil Capsules. Ease CBD Mist Spray 125mg 10ml. Blueberry Crack. Long Beach Edibles Chocolate Fudge Cookie 200mg THC. Rick Simpson Oil RSO, Full Extract Cannabis Oil For Sale.
Tetra Bites Edibles 10mg THC. Blackberry cheesecake strain. BLISS edibles 300mg THC. Buy OG Kush Strain For Sale Platinum OG Kush Cartridge 420. CBD YOU SOUR GUMMY VEGAN. 500mg CBD Strawberry FLAVA BLAST Keey. THC gummies 500mg THC. Buy Blue Dream Marijuana Online. CBD Dried Sardines CBDbits Medicated Cat Treats. Buy actavis promethazine codeine cough syrup drug.
400mg THC Keey flavoured Tinctures. 500mg CBD Key Lime Keey FLAVA BLAST. buy thc oil for vape pen. Mary s Sour Swirls Triple Strength Sativa. 200mg THC infused Ruby Chocolate. 80mg CBD JELLY BOMBS Twisted Extracts. Sour Diesel Sour D. Jack Herer Hash. Orange SATIVA JELLY BOMBS Twisted Extract. Mary s Feline 200mg CBD Oil. CBD Gummies Gummy Bears 1000mg. Mary s Rice Krispie Square Triple Strength Indica. Skywalker OG Weed Strain.
Mary s Sativa Bunnies Extra Strength. Puffco Plus V2 Wax Weed Vaporizer. 500mg CBD FLAVA BLAST- Bubble Gum Keey. BLISS edibles 200mg THC. 9 Pound Hammer THC Oil. CBD Prime Pet Health 200mg Pet Salve. Northen Lights. Magic Mushroom spore syringe B Cubensis. 500mg CBD Blackberry Keey FLAVA BLAST. CBD YOU WINE GUMMY VEGAN. 250mg CBD Oral Spray 10ml. Girl Scout Cookies. 100mg THC Hemp Seed Oil Capsules. THC Distillate. 500mg CBD Peach Mango Keey FLAVA BLAST.
200mg THC infused Milk Chocolate Adorable. 200mg THC infused White Chocolate Adorable. GSC THC Vape Oil For Sale 10 grams. Mary s 250mg Indica Extra Strength THC Capsules. Long Beach Edibles -Peanut Butter Cookie 200mg THC. Tetra Power Bites Edibles 30mg THC. 500mg CBD Cotton Candy FLAVA BLAST Keey. 125mg THC Oral Spray 10ml Ease. CBD Beef Tendersticks CBDbits Medicated Dog Treats. CARA-MELTS Twisted Extract. 200mg THC infused Gold Chocolate Adorable. Apple SATIVA JELLY BOMBS Twisted Extract.
Dry Ice Hash 30 grams. Mary s Sativa Bunnies Triple Strength. Lemon Skunk Weed Super Lemon Haze Strain. Butane Hash Oil BHO, Mail Order Dabs, Dab Oil For Sale. Tahoe og kush from the west coast tahoe weed strain tahoe kush for sale. 500mg CBD Mango FLAVA BLAST Keey. Strawberry Cheesecake Strain. Mary s Sour Swirls Extra Strength Sativa. Black Cherry INDICA ZZZ BOMBS Twisted Extract.
Platinum Bubba Strain, Pre 98 Bubba Kush For Sale. Orange SATIVA 1 1 JELLY BOMBS Twisted Extracts. Lemon Skunk Seeds Feminized Lemon Haze Seeds. Pineapple Express. Cannabis Oil 10. Cannabis 35. Cannabis Extract 7. CBD Pet Products 7. Concentrates 2. Cannabis seeds 1. CBD Products 6. Dried Magic Mushrooms 1. Drug store 33. Actavis Lean 1. Hybrid Weed 21. Feminized Cannabis seeds 1. Indica Strains 3. Indica vs Sativa 4.
Indoor Weed Seeds 1. khalifa kush strain. Raspberry INDICA ZZZ BOMBS Twisted Extract. CBD Oil Benefits CBD Hemp Oil For Sale Buy CBD Vape Oil. Magic Mushroom 1. Marijuana Oil 5. Marijuana Seeds For Sale 1. Medical Weed 17. Mushroom Dosage Chart 3. Marijuana vaporizers 1. Pure THC Oil Extract 5. Regular seeds 1. THC Vape Juice 5. THC Weed Hash oil for e cig 5. Vaporizers 2. Weed Concentrates 12. Weed Oil For Sale 6.
West Coast Cartridges 3. August 9, 2020 Best Cannabis Oil For Cancer. 420 mail order marijuana online. 420 mail order marijuana online without medical card cheap online dispensary shipping usa, legit online dispensary shipping nicola p iq option, online dispensary. Buying weed online without medical card. Welcome to the best online weed store near me in California where buying Cannabis oils for sale or mail order marijuana supply and buying weed online without medical card or script made easy.
You can order pure CBD products, high quality Cannabis oil with high THC level, Rick Simpson Oil for sale. And real cheap medical marijuana strains plus synthetic cannabis like Indica vs Sativa kush for sale online and have it delivered to your doorsteps mail box next day delivery worldwide. Mail order marijuana, THC oils for sale. Buy Pure THC Oils Online or High THC Vape Oils For Sale.
Best site to buy THC oils online or order pure THC vape oils for sale. Stop Searching for cannabis classifieds websites where you can get quality weed for sale online in USA or buy synthetic weed online Australia and how to buy real weed online UK, purchase weed online France, order marijuana Canada and all over the world. 420 Mail Order Delivery. We package our 420 mail order marijuana discreetly and ship overnight.
Buy mail order 420 cannabis online from our our mail order weed online store West Coast Cannabis Medical Marijuana Dispensary is the best place where you can buy marijuana online using debit credit cards. Buy kush online UK. Buy Marijuana Online Securely in Europe, Weed For Sale in USA, Mail Order Marijuana Canada, Buy Legal Kush Online Australia. At West Coast Cannabis Weed Shop100 customer security is guaranteed when ordering marijuana online from our 420 mail order dispensary.
Where you can buy grams of weed online or get cheap weed online discreetly with debit card. Hence you can use your credit card to buy cannabis online securely from our California kush store. Nobody does this better than us in this industry and now you can buy marijuana online securely and mail order marijuana products online with maximum privacy.
We re ensuring a smooth process of packaging and delivering your package at optimum discretion. Furthermore, It s never been easier to buy weed online without medical card and having your medical cannabis delivered straight to your doorsteps. Online Dispensary Shipping Worldwide Reviews. Buy marijuana online from the best Cannabis online store where you can Buy Concentrates Online USA UK and Canada Legal Weed For Sale Without Card. 420 USA Promotes relaxation.
Increases appetite Buy real weed online USA. Buy legal weed UK for Fights insomnia. Cheese Leafly Relieves pain. Mail Order Cannabis Removes headache. West coast synthetic wax review Improves mood. Buy Concentrates Online USA, Europe, Canada. 420 mail order USA, 420 mail order UKmail order 420 Canada and 420 mail order France. Order Medical marijuana which is any part of the marijuana plant that you use to treat health problems.
People use it to get relief from their symptoms, not to try to get high. Smoking marijuana kush via bongyou get chilled and purified smoke with the maximum amount of THC and CBD. Get weed bongs. Smoking Cannabis via bongyou get chilled and purified smoke with the maximum amount of THC and CBD. Buy Real Marijuana Online Australia United States and Canada with Europe. Weed Concentrates. Buy Weed Concentrates Online USA, UK, CA, Australia.
Sativa Strains 12. Latest high-performance indicator for the FLSC scale system. America s heavyweight among truck scales. Our truck scales provide you with tough, dependable vehicle weighing solutions that are built to last in demanding industrial environments. ZM155 Indicator. Our ZK810 high resolution digital counting scale. Flexible, high performance weight indicators specifically designed for hazardous environments. ZM Kiosk Vehicle Scale Controls.
Keep your truck scale operating safely, efficiently and smoothly without a dedicated operator. Your Industry. Find A Scale. Find the right weighing scales and equipment for your industrial sector. Find the best scale for you with our dynamic product finder. We provide service and maintenance for all kinds of equipment. A simple step towards reducing driver detention costs. Driver detention is such a hot topic for everyone in freight and logistics and rightly so.
It has an impact on the carrier, the driver and the customer. And it appears to be gradually getting worse, with delay lengths of over 2 hours increasing by 2. 8 every year and by 6. Alarmingly, this detention is costing the trucking industry over 1 billion a year in foregone profits. So, what can be done about it. It s easy to say that if shippers and receivers planned and organized better, communicating more with the carriers and drivers, then life would be easier.
9 on delays of over 6 hours. This sounds great. But what are the practical actions that can be taken to start making this issue better. We ve identified automating certain parts of the drivers journey at the loading unloading facility can not nicola p iq option speed up throughput, but also improve labor efficiency. Weight Indicators. Truck Scales. Our highly-intelligent digital weight and scale indicators are designed for any weighing application and are customizable to suit your needs.
Counting Scales. Highly accurate industrial counting scales for use in part counting and inventory control. Robust, accurate and built to last, these floor scales are available in a range of sizes and capacities to suit every application. Avery Weigh-Tronix is one of the world s leading suppliers of weighing scales, systems and equipment. Floor Scales. Our extensive range of Truck Scales are tough, dependable and built to last, even in harsh industrial environments.
We offer a wide range of industrial weighing systems and solutions, backed by an extensive service network throughout the USA. Part of a large corporate family, we market and service our products in over 80 countries across the globe. Bench Scales Checkweighers Counting Scales Forklift Truck Scales Load Cells Weigh Bar Platform Floor Scales Truck Scales Weight Indicators.
To look beyond what s expected. Iq option europe. To advance human health with newfound confidence. Ready for today, prepared for tomorrow. Disruption in action. The IQVIA Institute for Human Data Science. Discover the evidence, research and analytics underway that is helping accelerates our understanding of how health systems function, how treatment is evolving, and how care is being delivered. We want to make a difference in healthcare.
Careers at IQVIA. To get there it takes diverse skills and a curiosity to explore new possibilities. No matter your role, everyone at IQVIA contributes to our shared goal of improving human health. Find out how you can put your passions to work. Toll-Free only 1 866 267 4479. We re pleased to speak with you during our business hours. For international calls please refer to our toll-free list.
Fans are Back UK firms present Covid pass to PM. Ally Wolf No one chooses our industry for a normal life. Whether you re joining the University of Westminster soon or studying here already, the Student Accommodation Team offers help and advice on finding a suitable place to live. Harrow Hall. Location Harrow. For Undergraduates, postgraduates and study abroad students. Weekly rent 132. Location Marylebone. Weekly rent 187. Alexander Fleming Hall. Location Wembley Park. All our first year central London students are allocated at Raffles House.
For Undergraduates and postgraduates. Weekly rent 207. Rooms in our halls are open to full-time undergraduate and postgraduate students. See what the next steps are when you ve been offered a place in our halls. Accepting our halls offer. The Student Accommodation Code. Applying for halls. Location Hoxton. The University of Westminster Halls of Residence are covered by the Universities UK code of conduct for the Management of Halls of Residence.
The Code protects students rights to safe, good quality accommodation, wherever they are studying, and makes sure they get the best out of their time living in university or college residences. It outlines everything students can expect from their accommodation as well as their responsibilities as tenants. For more information please contact your Hall of Residence reception or visit the Universities UK website. Marylebone Hall. If you choose to live in private accommodation, or if you have been unsuccessful in your hall application, you have plenty of options.
If you d like to discuss your options in more detail with us, get in touch and we will do our best to help. Life in halls. The University of Westminster s Student Accommodation Team can help you with a variety of housing issues. As well as providing University halls of residence, the team can assist you in your search for alternative accommodation. If you have any questions or need help completing your halls application, get in touch with us using the contact details at the bottom of this page.
They also offer advice about issues such as tenancy agreements and dealing with landlords. Contact the Student Accommodation Team. 0207 911 5000, ext 65817 and 66127. University of Westminster, Student Accommodation, 35 Marylebone Road, London NW1 5LS Opening hours GMT 9am 5pm Monday to Friday. Semester One teaching 21 September 11 December 2020. Semester Two teaching 18 January 9 April 2021.
Be inspired by global best-practice, learn from leading edge data practitioners and take away pragmatic steps you can action nicola p iq option to drive revenue and create greater efficiencies. Tuesday 1 September 10 30am Virtual. Reposition marketing as a company growth engine. Free Webinar ACCC AdTech Inquiry, 27th August 10 30am. Topic will be ACCC AdTech Inquiry and ADMA response explained.
Thursday 27 August. Argentina Brazil Brazil English Brasil Português Canada Canada English Canada Français Colombia Mexico Mexico English México Español United States. Adriatic Belgium Belgium English Belgique Français België Nederlands Bulgaria Bulgaria English България Български Czech Republic Czech Republic English Czech Republic Česky Denmark España Finland France Deutschland Greece Greece English Ελλάδα Ελληνικά Hungary Ireland Israel Italy Italy English Italia Italiano. Advancing Biosimilar Sustainability in Europe.
Middle East Africa Nederland Nordics Norway Poland Portugal Portugal English Portugal Português Romania Romania English Romania Română Russia Russia English Россия и СНГ Русский Slovakia Slovakia English Slovakia Slovensky Sweden Switzerland Switzerland English Switzerland Deutsch Turkey Turkey English Türkiye Türkçe Ukraine Ukraine English Україна Українська United Kingdom. Asia Pacific Australia and NZ India Indonesia Malaysia Pakistan Philippines Singapore Sri Lanka Thailand Vietnam. Overview COVID-19 Research Development Clinical Trials Functional Services Virtual Trials Consulting.
Overview Real World Data and Insights Study Design Platforms Evidence Networks Health Economics Value Regulatory and Safety. Overview COVID-19 Commercialization Launch Strategy and Management Brand Strategy and Management Pricing and Market Access Healthcare Professional Engagement Patient Engagement Promotional Strategy. Overview Safety Pharmacovigilance Regulatory Compliance Quality Compliance Commercial Compliance.
Overview Clinical Acceleration Patient Engagement Content Management Customer Engagement Safety Regulatory Quality Performance Management Insights Information Management Partner Programs. Overview Pharmaceutical Manufacturers Emerging Biopharma Consumer Health MedTech Generics Information Partner Services Financial Institutions Public Health and Government Patient Associations Payers Providers. Featured Capabilities.
Human Data Science Cloud Innovative Models. Overview Artificial Intelligence and Machine Learning Virtual Research Genomics Digital Health. Overview Oncology Rare Diseases Central Nervous System Infectious Diseases and Vaccines GI and Hepatology Diabetes Pediatrics Biosimilars. IQVIA Insights Blogs, White Papers, Webinars IQVIA Institute. Our Story Human Data Science IQVIA CORE Executive Team.
Contact Locations Investors News Events Privacy Careers. Working at IQVIA Life at IQVIA See all jobs. Insights The IQVIA Institute Reports Advancing Biosimilar Sustainability in Europe. About the Report. A growing number of biologic medicines have been developed and approved over the past decade, improving the lives of patients worldwide. However, patient access to biologics has been limited, partly due to their relatively high cost.
Biosimilars are increasingly available across Europe, bringing with them the opportunity to generate competition for biologic therapies and thereby lower medicine costs and increase patient access. This report puts forth a framework for the evaluation of sustainability in the biosimilars market and identifies its key policy elements.
Based on these criteria, current policies and market dynamics are assessed to identify where risks to sustainability exist and the best practices that can support the long-term positive contribution of biosimilars in Europe. Report Summary. Biosimilars are now an integral part of the market for biologics, which accounted for 277 billion in sales globally in 2017 and is projected to reach 452 billion by 2022.
Use of biosimilars in the EU5 countries alone stands to offer savings of more than 10 billion between 2016 and 2020. To sustain the market for biosimilars in the long-term, ongoing benefits for all stakeholders must be ensured. Sustainable policies therefore provide for patient access and physician prescription choice, provide a means to manage existing healthcare budgets for payers, and safeguard a healthy level of competition, supply, and product safety and quality. Current European policies and market dynamics were assessed to identify the risks and challenges to sustainability, with the aim to identify best practices that can be leveraged to support long-term sustainability of the biosimilars market in Europe.
Overall, biosimilars have increased patient access to biologic medicines, and this growth is supported by a regulatory environment and clinical guidelines that create a neutral or positive climate for biosimilars relative to originator biologics, and thus supports their sustainability. However, some elements of a sustainable system were found to potentially be at future risk due to payer driven-switch and specific purchasing systems.
Specifically, payer-driven switch was found to reduce physician prescription choice, potentially leading to loss of product options currently working for patients and reducing patient involvement in the treatment decision. Additionally, single-winner tenders were found to disrupt market forces and competition, thereby not supporting long-term sustainability. Several alternative policies currently in place in Europe can be leveraged to ensure and support the long-term sustainability of the biosimilars market while additionally fulfilling the needs of all stakeholders.
Key Findings. Sustainability in the biosimilars marketplace ensures benefits for all stakeholders. Biosimilars are a key means to alleviate nicola p iq option challenges faced by many stakeholders in the currently constrained European budgetary environment. Elements of biosimilar sustainability represent the needs of all stakeholders including patients, physicians, payers and manufacturers and support the healthy functioning of the marketplace for medicines.
Policies can influence the achievement of these elements variably, and it is therefore valuable to explore which current biosimilar policies in Europe best secure a sustainable environment supporting these. Launch of a biosimilar brings with it increased patient use of biologic medicines. In the years following biosimilar launch, significant growth is seen in the use of biologic molecules.
However, growth often slows to pre-launch levels within a few years, reflecting the declining competitiveness of the molecule itself within a market that includes innovative therapies. Uptake also varies by country; in Norway, where biosimilars are strongly promoted by health authorities, and national tenders are used, uptake is fast and use of biologic medicines grow.
In contrast, in countries like Italy, where health authorities have a more conservative perspective regarding biosimilars, the uptake has been slower. Faster and higher biosimilar penetration is seen when national tenders are run as single tenders with single winners, as in the case of Norway and Denmark, however this mechanism was found to jeopardise long-term sustainability.
The European regulatory environment and clinical guidelines are generally positive toward sustainability. Overall, the current European regulatory environment creates a neutral or positive environment for biosimilars relative to originator biologics and supports sustainability. However, two potential areas pose a risk to sustainability payer-driven switch and tender systems that award total molecule market volume to a single competitor.
Payer-driven switch was found to reduce physician prescription choice, potentially leading to loss of product options currently working for patients and to reduce patient involvement in the treatment decision. Although single-winner tenders were found to achieve greatest price reduction on biologic products when biosimilar competition exists, they were also found not to support long-term sustainability as they disrupt market forces and competition by excluding nonwinner manufacturers from the market for the duration of the tender contract.
Additional evidence suggests single-winner tenders do not always optimise savings, since physicians can still use non-preferred product at a higher price; whereas multi-winner tenders offer price reductions on all contracted products. Several policies currently in place in Europe can be leveraged to support the long-term sustainability of the biosimilars market.
Based on sustainable policies currently in place in Europe, a set of best practices can be leveraged to ensure long-term sustainability of the biosimilars market, while additionally fulfilling the needs of all stakeholders. These include creating positive incentives to promote biosimilar uptake, taking steps to ensure that physicians retain prescription freedom to offer the best product selection for a specific patient and designing tenders and contracts to have multiple winners and include criteria other than price.
Report Charts. Chart 1 Availability of Biosimilars in Europe. Chart 2 The EMA s Definitions of Interchangeability, Switch and Substitution. K Example of a National Framework for Biosimilar Commissioners. Chart 4 A Multi-Stakeholder Definition of Sustainability for the Biosimilar Marketplace. Chart 5 Biosimilar Sustainability Assessment Framework Key Areas.
Chart 6 Biosimilar Sustainability Assessment Framework Qualitative and Quantitative Metrics Examined. Chart 7 Countries and Molecules Assessed. Chart 8 Growth in Molecule Utilisation Across Countries with Successfully Adopted Biosimilars, as a Percentage of 2012 Values. Chart 9 Growth in Utilisation by Country of all Molecules Exposed to Biosimilar Competition Where Biosimilars Were Successfully Adopted, as a Percentage of 2012 Values.
Chart 10 Time to First Sales for Biosimilars versus Branded Products by Country. Chart 11 Infliximab Biosimilar Prescribing Targets Set by KVs and KVB in Germany. Chart 12 Biosimilar Penetration in Norway Over Time. Chart 13 Biosimilar Penetration in Denmark and France. Chart 14 Infliximab Per DDD Product Costs by Swedish Country in Relation to Use of Single- Versus Multiple-Winner Tenders, Q1 2018. Chart 15 Competition in Germany. Chart 16 Percent Difference Between Biosimilar and Originator Price at Biosimilar Launch by Country.
Chart 17 List and Net Prices in Germany, as Percent of Originator List Price. Chart 18 Biosimilar Sustainability Metrics Across Countries Based on Existing Policies. Chart 19 Payer-driven Switch Scenarios Impact on Sustainability in the Biosimilar Marketplace. Chart 20 Tendering Scenarios Impact on Sustainability in the Biosimilars Marketplace. Chart 21 Best Practices to Achieve Sustainability for All Stakeholders in the Biosimilars Market.
Chart 22 Metrics to Evaluate. Chart 23 Multi-Stakeholder Assessment. IQVIA Institute Inquiries. We are ready to help you better understand and benefit from the work of the IQVIA Institute for Human Data Science. Please get in touch today to learn more. So that you can get your new wheels quicker, we have most of our alloy wheels in stock.
At Elite Wheels Tyres in Reading, Berkshire, we supply and fit an extensive range of alloy wheels from all major manufacturers, including Wolfrace, Bola, AC, Calibre and more. If you re looking for a new set of aftermarket alloy wheels, you ve come to the right place. Buy your alloys online, and we ll provide national shipping, or for international shipping please order via telephone. Simply enter your vehicle details in the search feature above, and find all available alloys for your car.
Our expert team also offer complete alloy wheel fitting services at our Reading depot, so don t have the hassle of dealing with multiple companies. For all your alloy wheel supply and fitting needs, look no further than our expert team at Elite Wheels Tyres. Browse our range of aftermarket alloys below, and order online. Can t Find your Alloys Online. If you can t find the product you want on our online store, don t panic. We will endeavour to source them for you, or alternatively, find you the next best thing.
You can also contact us via form, quoting the name of your chosen wheels. For enquiries on any products, listed in our online store or not, call our friendly team today on 0118 950 4100. Elite Wheels Tyres Limited is a limited company in England Wales Company number 03579893 Registered address 3A Bridgewater Close, Reading, Berkshire RG30 1JT. Address 3A Bridgewater Close, Reading, Berkshire RG30 1JT, UK.
Home OEM Alloy Wheels Aftermarket Alloy Wheels Buy Tyres Online Alloy Refurbishment Wheel Alignment Gallery Contact Us PayPal Credit Sitemap. Opening Times Monday Friday 8 00AM - 5 00PM Saturday 8 00AM - 12 00PM. Telephone 0118 950 4100. The content on this website is owned by us and our licensors. Do not copy any content including images without our consent. Aftermarket Alloy Wheels For Sale Online. Ultra slim slider with unmatched performance. Triple Glazed Sliding Doors.
60 slim sliding door from panoramah is unmatched in design, performance, and security. With the use of advanced glazing engineering the slim system offers sightlines of just 20mm with triple glazed units. The oversized sliding triple glazed units can reach unprecedented sizes of 9m tall and wide offering thermal insulation values that achieve Passivhaus and Minergie standards.
This sliding system is a ground-breaking exterior opening system offering architects the nicola p iq option to push the boundaries, change the nature of the building envelope and connect interiors with exteriors. 60 system stands out for its intrusion protection. As well as offering extreme oversized glass sizes, the ah. The system has been tested to achieve RC4 security rating which far out surpasses the requirements for PAS24 and Part Q security requirements for projects in the UK.
The floor to ceiling sliding glass doors offer glass faces of up to 29m 2 per sliding unit. Even at these sizes the insulated glass units slide effortlessly, gliding along the stainless steel mechanisms as if weightless. Oversized Glass Doors. With a deeper glass rebate than the ah. This allowance for increased glass specifications is what permits the oversized sliding door system to achieve such high and unparalleled levels of thermal insulation from a minimalist nicola p iq option.
You can achieve Uw values of 0. 8 W m2K easily with improved sound insulation of 44dB. 60 system allows the integration of highly insulating triple glazed units into your glass façade. The increased performance does not stop at the insulation values. Even at extremely large sizes the slim sliding door system offers extreme weather protection, making it suitable for use in even the harshest environment.
With water resistance testing surpassing the basic classes to achieve a class of E900 it is evident that this minimal window can be used on areas where harsh driving rain is common. As with the ah. 38 system, the ah. 60 offers design flexibility with a range of modular sliding configurations possible including linear sliding, Juliet balconies, corner opening and pocket doors as well as vertical and descending sliding windows. All exterior detailing maintains the design ethos of minimalism with all outer framing able to be hidden within building reveals.
Performance of Slim Sliders. Thermal performance values start with Uw values of 0. 8 W m 2 K using insulating triple glazing with Ug value 0. The use of triple glazing also allows increased sound insulation of 44 dB. 38 slim slider, the ah. Air permeability has been tested at Class 4, wind resistance at Class C5 and water resistance at E900 which shows it surpassed the basic testing classes and achieved water tightness with driving water pressures of 900 Pa.
Another key aspect of the ah. 60 triple glazed slider is the enhanced security. It has been tested to RC4 WK4 European security ratings. This rating is a much higher security specification than the required PAS24 testing required for UK new build properties. This high-level security has allowed the minimalist slider to be used on some of the world s most security conscious residences. If higher levels of wind and weather resistance is required, the panormah.
HVHZ system is fully tested to cyclic wind environments and hurricane storm resistance. Impressive Oversized Glass. Large panes of sliding glass offer unprecedented avenues of design for architects. 60 sliding system has been tested at extreme sizes with opening doors of 9000mm tall or 9000mm wide. The exposed glass face can be up to 29m 2 per unit and sliding units can be up to 1000kg.
Even at those impressive and defying sizes, even larger glass sizes are possible on investigation. The team at IQ are ready to work with architects to engineer our systems to their required specifications. The stainless-steel rails and sliding mechanisms of the ah. 60 system mean that even at these large sizes sliding operation is smooth.
Automation is not required until the panel weights exceed 850kg. and if automation is required it is fully integrated, hidden and in keeping with the minimalist design details of the panoramah. system family. vertical sash window. Portland Road Double Height Slim Sliding Doors. Renovations and Refurbishments. Shenfield Mill Contemporary Extension Floating Roof. The Lea Oversized Glass Sliding Doors. Buckingham Gate Slim Frame Sliding Glass Doors.
60 Product Data Sheet. Choosing Specifying Sliding Doors EBook. Media release Monday, June 18, 2018. Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery. Better visual outcomes for patients with the AcrySof IQ PanOptix intraocular lens at near and intermediate distance vision 1 Detailed findings presented at World Ophthalmology Congress 2018 Recent survey reveals 82 of people 60 are willing to have advanced surgical options to treat their cataracts and at the same time improve their vision 2.
Barcelona, Spain, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens IOL compared to the ZEISS AT LISA tri 839MP IOL. These findings further strengthen the value of the PanOptix IOL ENLIGHTEN optical technology, to provide enhanced image quality and more comfortable near to intermediate vision setting the AcrySof IQ PanOptix IOL apart from other trifocal IOLs.
Results from a head-to-head study involving 180 patients were presented today at the World Ophthalmology Congress WOCheld June 16-18, 2018 in Barcelona, Spain. These results underscore the strength of the PanOptix IOL portfolio, and affirm the value of the AcrySof IQ PanOptix IOL for surgeons who want to treat cataracts and correct presbyopia in a single surgery. While 82 of people over 60 are open to this type of advanced surgical option 2only a few patients are even aware that trifocal IOLs like the AcrySof IQ PanOptix IOL exist, said Michael Onuscheck, President General Manager, Global Surgical Franchise, Alcon.
As the leader in eye care, it s Alcon s responsibility to continue to deliver innovation that improves patient outcomes, and to connect patients to educational resources that can inform their treatment decisions. AcrySof IQ PanOptix is the first hydrophobic trifocal lens built on Alcon s proven AcrySof IQ platform. Unlike other leading trifocal IOLs, AcrySof IQ PanOptix has an intermediate focal point at 60 cm, the distance for common intermediate vision activities like using a computer or reading a menu, combined with the excellent rotational and axial stability of the AcrySof single piece design 3.
The design features of the AcrySof platform with the ENLIGHTEN Optical Technology are intended to help patients adapt more naturally to their new lens. The ENLIGHTEN Optical Technology provides an exceptionally high light utilization 88 and less pupil dependence 4,5,6 than previous generations of multifocal IOLs. This lens features a comfortable and continuous range of near to intermediate vision without compromising distance vision.
At distance vision, AcrySof IQ PanOptix IOL performance is comparable to AT LISA tri 839MP, but at near and intermediate distance, AcrySof IQ PanOptix shows significant superior visual outcomes 1. These clinical results confirm the superior performance of the Alcon trifocal IOL to perform daily activities like reading books or looking at tablet and smartphone screens, said Ruth Lapid-Gortzak, MD, PhD, Department of Ophthalmology, Academic Medical Center, University of Amsterdam, Netherlands and the Global Coordinating Investigator of the clinical trial.
Results from the trial will be presented during the WOC Congress on Monday, June 18, 14 00-18 00 - Cataract E-Poster Pod Session III. This prospective, multi-center, randomized, double-masked, post-market clinical study involved bilateral implantations and followed 180 patients for six months. The study was designed to clinically qualify bench studies and model predictions of the visual performance of AcrySof IQ PanOptix and the AT LISA tri 839MP Presbyopia Correcting IOL.
Results showed the AcrySof IQ PanOptix group had superior visual outcomes at six months in uncorrected intermediate visual acuity at 60 cm p 1. To raise patient awareness on cataract treatment options, Alcon has developed the More to See campaign, including a survey conducted in 12 countries across Europe, Middle East and Africa in 2017 to understand the knowledge on cataract disease and treatment of consumers aged 60 and over.
Results showed that few people 39 are aware that some surgical options for cataract treatment can also provide vision correction. When asked, the majority 82 would be willing to have an advanced surgical option that could treat their cataract and improve their vision. These results shows the need for further patient information at time of cataract surgery 2. More details are available on www. AT LISA is a registered trademark owned by or licensed to ZEISS.
About Cataracts. Cataracts are one of the most common age-related eye conditions and one of the leading causes of vision loss 7. The World Health Organization WHO estimates that nearly 18 million people are bilaterally blind from cataracts in the world, making the condition responsible for almost half of all global cases of blindness 8.
A cataract is a cloudy area in the naturally clear lens of the eye that affects vision. The vast majority of cataracts happen because of normal aging, but radiation exposure, taking steroids, diabetes, and eye trauma can accelerate the development of cataracts 9. As a cataract develops, the eye s lens gradually becomes cloudy, allowing less light to pass through, which makes it more difficult to see 10. About the AcrySof portfolio. The AcrySof IQ portfolio comprises monofocal, toric and multifocal IOLs to address the individual needs of patients with cataract.
The AcrySof IQ IOL platform leverages a unique BioMaterial, high-performance BioMechanics and advanced BioOptics to help maximize cataract patient outcomes. Since its first launch in 1994, the AcrySof IOLs have been implanted more than 100 million times, improving the sight and lives of tens of millions of patients over the past 20 years. Important Information about AcrySof PanOptix IOLs. AcrySof IQ PanOptix was launched in 2015, it is currently available in more than 70 countries worldwide.
As with any surgical procedure, there are associated risks. Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk benefit ratio before implanting a lens of this type. This is particularly so in a patient with any of the conditions described in the AcrySof IQ PanOptix physician labeling. Some patients may experience visual disturbances and or difficulty seeing due to the multifocal lens design, especially under dim light conditions.
As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explanation of an AcrySof IQ PanOptix IOL. Posterior capsule opacification PCO may significantly affect the vision of patients with multifocal IOLs sooner in its progression than in patients with monofocal IOLs. This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995.
Forward-looking statements can generally be identified by words such as potential, can, will, plan, expect, anticipate, look forward, believe, committed, investigational, pipeline, launch, or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements.
Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements.
There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future.
Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political and economic conditions; safety, quality or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG s current Form 20-F on file with the US Securities and Exchange Commission.
Lapid-Gortzak R, Duch F, Elies D, Guarro M, Martinez A. Multicenter Visual Outcomes Comparison of Two Trifocal Presbyopia Correcting IOLs 6 Months Post-op Results. World Ophthalmology Congress. Barcelona 2018. More to See campaign survey EMEA. Alcon data on file. January 2017 Lee BS, Chang DF. Comparison of the Rotational Stability of Two Toric Intraocular Lenses in 1273 Consecutive Eyes.
Ophthalmology 2018 Gundersen GK, et al. Trifocal intraocular lenses a comparison of the visual performance and quality of vision provided by two different lens designs. Clinical Ophthalmology 2017 11 1081 1087. Estimation of Light Energy Distribution for PanOptix IOL. Alcon data on file, 2015. García-Pérez et al. Short term visual outcomes of a new trifocal intraocular lens. BMC Ophthalmology 2017 17 72.
Prevent Blindness. Vision Problems in the U. Accessed April 2017. The International Agency for the Prevention of Blindness. Accessed April 2018. American Optometric Association AOA. Causes of Cataract. Accessed May 2017. Cleveland Clinic. Accessed August 2015. About Novartis. Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care.
Novartis has leading positions globally in each of these areas. In 2017, the Group achieved net sales of USD 49. 1 billion, while R D throughout the Group amounted to approximately USD 9. Novartis Group companies employ approximately 124,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. Novartis is on Twitter.
For Novartis multimedia content, please visit www. For questions about the site or required registration, please contact email protected. About Alcon. Alcon is the global leader in eye care. As a division of Novartis, we offer the broadest portfolio of products to enhance sight and improve people s lives. Our purpose is reimagining eye care, and we do this through innovative products, partnerships with eye care professionals and programs that enhance access to quality eye care.
Learn more at www. Alcon is on Facebook. Novartis Media Relations. Central media line 41 61 324 2200. Our products touch the lives of more than 260 million people each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors, and there are millions more who are waiting for solutions to meet their eye care needs. Eric Althoff Novartis Global Media Relations 41 61 324 7999 direct 41 79 593 4202 mobile email protected.
Coments:05.02.2020 : 23:59 Dugami:
Subscribe to the M G.
29.01.2020 : 23:13 Gozshura:
Básicamente, se trata de interés pagado por anticipado y cada punto equivale al 1 del monto total del préstamo.
01.02.2020 : 11:16 Vudocage:
Icon Feedback Error.